2. Inflammation/Immunology

Inflammation/Immunology

Inflammation/Immunology

Related Products

PDF 93.1 MB

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P990701
    Lomvastomig 2648840-52-0 99.9%
    Lomvastomig is an anti-PDCD1/HAVCR2 human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
    Lomvastomig
  • HY-P990702
    Pradusinstobart 2642171-66-0
    Pradusinstobart is an anti-PDCD1 human IgG4 κ monoclonal antibody. Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Pradusinstobart
  • HY-P990899
    Amostomig 2889449-09-4
    HY-P990899 is an CD274/CD47-targeting IgG1λ2 type humanized antibody, the recommed isotype control is Human IgG1 lambda2, Isotype Control (HY-P990096).
    Amostomig
  • HY-P990900
    Ansipastobart 2829250-32-8
    HY-P990900 is an NT5E-targeting IgG1λ2 type human antibody, the recommed isotype control is Human IgG1 lambda2, Isotype Control (HY-P990096).
    Ansipastobart
  • HY-P990909
    Calotatug 2254097-05-5 98%
    HY-P990909 is an ERBB2-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Calotatug
  • HY-P990930
    Mozistobart 2852752-92-0 99.21%
    HY-P990930 is an CD22-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Mozistobart
  • HY-P990939
    Podentamig 2851863-52-8 98%
    HY-P990939 is an CD3E/TNFRSF17-targeting VH-VH'-(scFv-heavy -λ) type chimeric antibody.
    Podentamig
  • HY-P990945
    Tazlestobart 2850355-80-3 99.66%
    HY-P990945 is an CTLA4-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Tazlestobart
  • HY-P990949
    Umikibart 2851478-58-3 98.70%
    HY-P990949 is an HGF-targeting IgG4κ type humanized antibody, the recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Umikibart
  • HY-P990950
    Vebanvibart 2937321-40-7
    HY-P990950 is an SARS-CoV-2-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Vebanvibart
  • HY-P990955
    Ebribafusp alfa 2839652-75-2 98%
    Ebribafusp alfa (ADX-097) is a bifunctional fusion protein composed of a humanized anti-C3d monoclonal antibody linked to the first five common repeat (fH1-5) domains of two complement factors H. Ebribafusp alfa is a tissue-targeted complement inhibitor designed to inhibit complement activity at the lesion site while minimizing systemic complement blockade. Ebribafusp alfa can be used for research on kidney diseases, lupus nephritis, and complement component 3 glomerulonephropathy. The recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Ebribafusp alfa
  • HY-P990958
    Invikafusp alfa 2894138-60-2 98%
    HY-P990958 is an T cell receptor germline-encoded variable chain Vβ6/β10-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Invikafusp alfa
  • HY-P990959
    Lesigercept 2878448-12-3 98%
    Lesigercept is a recombinant fusion protein comprising an FcERI (IgE Fc receptor subunit alpha) fused to a human IgG4 Fc.
    Lesigercept
  • HY-P990960
    Lucorafusp alfa 2769742-99-4 98.14%
    HY-P990960 is an TIGIT-targeting IgG4κ type humanized antibody, the recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Lucorafusp alfa
  • HY-P990962
    Vislarafusp alfa 2850355-96-1 98%
    HY-P990962 is an EGFR/CD47-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Vislarafusp alfa
  • HY-P990965
    Efparepoetin alfa 2761347-19-5 98%
    Efparepoetin alfa is an EPO receptor agonist. Efparepoetin alfa can be used in the research of anemia caused by chronic kidney disease.
    Efparepoetin alfa
  • HY-P990970
    Armocibart 2857858-84-3
    HY-P990970 is an TFPI-targeting IgG4κ type human antibody, the recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Armocibart
  • HY-P990971
    Atenastobart 2817644-49-6 98.473%
    HY-P990971 is an TNFRSF9-targeting IgG1λ2 type human antibody, the recommed isotype control is Human IgG1 lambda2, Isotype Control (HY-P990096).
    Atenastobart
  • HY-P990975
    Birinkibart 2894136-82-2 98.26%
    HY-P990975 is an CSF2RB-targeting IgG4κ type human antibody, the recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Birinkibart
  • HY-P990978
    Caxmotabart 2930815-95-3
    HY-P990978 is an ERBB2-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Caxmotabart
Cat. No. Product Name / Synonyms Application Reactivity